Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme's Defense Against Hostile Sanofi Takeover Is Time
Bloomberg
Thursday, October 7, 2010 - 11:41am
tags:
hostile bid, Sanofi, M&A, Genzyme
Vical signs deal to make HIV vaccines
Yahoo/AP
Thursday, October 7, 2010 - 8:11am
tags:
Vical, vaccines, HIV
Those Pharma Job Cuts Just Keep On Coming
Pharmalot
Thursday, October 7, 2010 - 8:10am
tags:
layoffs
Novartis, Synthetic Genomics in flu vaccine deal
Marketwatch
Thursday, October 7, 2010 - 8:08am
tags:
vaccines, Synthetic Genomics, Novartis, flu vaccine
Sucampo, Abbott file in Japan on constipation drug
Marketwatch
Thursday, October 7, 2010 - 8:07am
tags:
Abbott Laboratories, Sucampo, Japan, constipation, Amitiza
China Demand to Help Increase Global Drug Sales to $880 Billion, IMS Says
Bloomberg
Thursday, October 7, 2010 - 7:06am
tags:
China, drug sales
Will Jazz's Rekinla Get FDA's OK?
Motley Fool
Thursday, October 7, 2010 - 7:03am
tags:
Jazz Pharmaceuticals, Rekinla, FDA, fibromyalgia
Biocon May Sell Oral Diabetes Drug to Pfizer, Bloomberg UTV Says
Bloomberg
Thursday, October 7, 2010 - 7:01am
tags:
Biocon, Pfizer, diabetes, insulin
InterMune sells Hep C drug rights to Roche
Marketwatch
Wednesday, October 6, 2010 - 6:54pm
tags:
hepatitis C, InterMune, Roche, danoprevir
Court Says Teva Can Challenge Eisai Patents, Hurting Indian Rival Ranbaxy
Bloomberg
Wednesday, October 6, 2010 - 6:52pm
tags:
Teva Pharmaceuticals, India, Eisai, patents, Ranbaxy
Why Some Pharmaceutical Sales Managers Hate to Manage Professional Representatives
Pharmareform
Wednesday, October 6, 2010 - 6:47pm
tags:
sales managers, drug reps
Celgene Is All Grown Up
Motley Fool
Wednesday, October 6, 2010 - 3:00pm
tags:
Celgene
Pfizer closes purchase of FoldRx Pharmaceuticals
Yahoo/AP
Wednesday, October 6, 2010 - 2:59pm
tags:
M&A, FoldRx, Pfizer
It Lives!! Apotex Asks the Supreme Court to Review Generic COZAAR/HYZAAR 180-Day Exclusivity Decision
FDA Law Blog
Wednesday, October 6, 2010 - 11:55am
tags:
generics, Cozaar, patents, FDA, Supreme Court, Hyzaar, Apotex
Pharma cuts 6,000+ jobs in Sept.
Fierce Pharma
Wednesday, October 6, 2010 - 11:23am
tags:
layoffs
Progenics gets $4.1M grant for infection treatment
Yahoo/AP
Wednesday, October 6, 2010 - 11:22am
tags:
grants, Progenics Pharmaceuticals, Clostridium Difficile
Pfizer may divest its Capsugel business
Marketwatch
Wednesday, October 6, 2010 - 10:16am
tags:
Pfizer, drug delivery, Capsugel
Will Private Equity Rescue Genzyme? Unlikely
NY Times, NY
Wednesday, October 6, 2010 - 10:14am
tags:
private equity, M&A, Genzyme, Sanofi
Shrinking U.S. Biotechnology Sector Lost 25% of Companies in Past 3 Years
Bloomberg
Wednesday, October 6, 2010 - 10:14am
tags:
biotech
What Investors Think About Cerus
Motley Fool
Wednesday, October 6, 2010 - 10:12am
tags:
Cerus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.